All News

Rivaroxaban is the first and only therapy indicated for both coronary artery disease and peripheral artery disease.

This month's featured products include lopinavir and ritonavir tablets, osimertinib tablets, and more.

Directions in Oncology Pharmacy is getting to know oncology pharmacy professionals through a series of interviews. In this issue, we talk to Ashley E. Glode, PharmD, BCOP, who was recently named an Advocacy Champion by the American Society of Clinical Oncology (ASCO).

Hospitalizations related to C. diff infections can cost more than twice as much as the average hospitalization and can extend patients’ stays by an average of 3.6 days.

This research lays the foundation for future clinical trials aimed at investigating whether moderate to vigorous exercise can minimize “chemo brain,” which is a decline in cognitive function many patients with breast cancer experience.

Ten quiz questions to assess your knowledge on common osteoporosis treatments.

Walgreens also announced expanded age eligibility for flu shots, with pharmacy team members able to vaccinate patients 3 years of age and older.

Rylaze was granted Fast Track Designation by the FDA in October 2019 for acute lymphoblastic leukemia and was approved as part of the Real-Time Oncology Review program.

Chronic kidney disease (CKD)-associated pruritus is a systemic itch condition occurring with a high frequency and intensity in patients with CKD undergoing dialysis.

When direct oral anticoagulants are taken, especially for the first time, patients may be at risk of bleeding.

The pharmacist can provide information and support that patients with cancer need to get through what might be the most challenging time of their lives.

Washington state's House Bill 5203 allows health care authority to partner with other agencies to produce, distribute, and purchase the drugs.

Vaccine-related updates seem to be made on a weekly basis and keeping up to date on recommendations can be difficult.

18th century author William Withering popularized the medical use of digitalis, the source for cardiac medication Digoxin.

It is the responsibility of the pharmacist to remain informed of all existing and new drugs for the treatment of Alzheimer disease, especially because novel and investigational drugs may target the pathophysiology of the disease.

The first fully approved vaccine for COVID-19 will be marketed under the name Comirnaty.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Prescription labels have a lot of details on them, which can make it difficult for patients to find and use important information.

Col. Dallas Hack, director of medical affairs at MagicMed, discusses the drug development program of a novel derivative of psilocybin for the treatment of post-traumatic stress disorder.

Cheryl Larson, president and CEO of Midwest Business Group on Health, discusses current efforts to manage drug spend and the high cost of specialty drugs on the market.

Additionally, among this population, combining aerobic exercise with a moderate reduction in daily calories resulted in greater improvements in aortic stiffness versus exercise only or exercise plus a more restrictive diet.

Vitamin K works against warfarin and can be used as an antagonist for it.

Median disease-free survival was nearly twice as long among patients with urothelial carcinoma who received nivolumab compared with placebo.

Kristin Ferguson, DNP, RN, OCN, outlined 4 principles for the reimbursement of oncology drugs, diagnostics, and biomarker testing that were recently released by the Association of Community Cancer Centers.

STRO-002 is a folate receptor alpha-targeting antibody drug conjugate for the treatment of patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received 1 to 3 prior lines of systemic therapy.

This month's featured products include the pneumococcal 20-valent conjugate vaccine, semaglutide injection, and more.

The agents that have been evaluated and approved, and those that are coming in the pipeline, make for an exciting time to consider directed therapies.

This week’s recommendation by the Biden administration for booster shots to combat COVID-19 is a call to action for pharmacists to get ready for the upcoming flurry of activity.